YS Biopharma (YS) Appoints Six New Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company", and together with its subsidiaries, "YS Group"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the appointment of six new members to its Board of Directors (the "Board"), effective February 13, 2024. The six new directors are: Dr. Yuntao Cui; Dr. Jin Wang; Mr. Henry
Hong Kong’s Yang & Yang Solicitors, which spun off last year from Deloitte Legal, has hired veteran corporate lawyer Rossana Chu as a partner. Chu was previously the managing partner of LC Lawyers, EY’s Hong Kong law firm, which closed recently.
In the dynamic field of law, Asia has seen exceptional litigators who have made a lasting impact. These top-tier professionals are widely recognized for their achievements and dedication to justice.
Stephenson Harwood has expanded its partner strength in Hong Kong with the hires of transaction specialist Danny Kan and disputes expert Dorothy Siron. They join as partners from Ping An Group and Zhong Lun Law Firm, respectively.